← Back to directory

Peter Valent

Researcher Next ID · RN-030128

Researcher · Immunology and Microbiology

Ludwig Boltzmann Institute Applied Diagnostics

Vienna, Austria

Not currently recruitingFunding unknown
Works count
1,479
Citation count
73,726
H-index
132
i10-index
832

Research interests

Immunology and Microbiology
Medicine
Mast cells and histamine
Acute Myeloid Leukemia Research
Chronic Myeloid Leukemia Treatments
Eosinophilic Disorders and Syndromes
Food Allergy and Anaphylaxis Research

Publications

  • Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    NEJM Evidence · 2022 · https://doi.org/10.1056/evidoa2200008

  • Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab674

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-1008-z

  • Anemia at older age: etiologies, clinical implications, and management

    Blood · 2017 · 10.1182/blood-2017-07-746446

  • Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine

    Journal of Innate Immunity · 2016 · 10.1159/000443526

  • Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

    Blood · 2016 · 10.1182/blood-2016-09-731893

  • Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1513098

  • Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

    Nature · 2015 · 10.1038/nature14898

  • Mast Cells, Mastocytosis, and Related Disorders

    New England Journal of Medicine · 2015 · 10.1056/nejmra1409760

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Journal of Allergy and Clinical Immunology · 2015 · 10.1016/j.jaci.2015.08.034

  • Cancer stem cell definitions and terminology: the devil is in the details

    Nature reviews. Cancer · 2012 · https://doi.org/10.1038/nrc3368

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Blood · 2012 · https://doi.org/10.1182/blood-2012-03-420489

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

    Journal of Allergy and Clinical Immunology · 2012 · https://doi.org/10.1016/j.jaci.2012.02.019

  • New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

    Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.35.6394

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    International Archives of Allergy and Immunology · 2011 · 10.1159/000328760

  • RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

    Nature · 2011 · https://doi.org/10.1038/nature10334

  • Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

    European Journal of Clinical Investigation · 2007 · 10.1111/j.1365-2362.2007.01807.x

  • New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

    Blood · 2007 · https://doi.org/10.1182/blood-2007-03-082404

  • Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

    Leukemia Research · 2007 · 10.1016/j.leukres.2006.11.009

  • Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

    Blood · 2007 · 10.1182/blood-2007-07-102061

  • Vaccination with genetically engineered allergens prevents progression of allergic disease

    Proceedings of the National Academy of Sciences · 2004 · 10.1073/pnas.0404735101

  • Diagnostic criteria and classification of mastocytosis: a consensus proposal

    Leukemia Research · 2001 · https://doi.org/10.1016/s0145-2126(01)00038-8

  • Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture

    Blood · 1992 · 10.1182/blood.v80.9.2237.2237

  • Profilins constitute a novel family of functional plant pan-allergens.

    The Journal of Experimental Medicine · 1992 · 10.1084/jem.175.2.377

  • Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals

    Science · 1991 · 10.1126/science.1857985

Current projects

    No projects listed.